- Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
- Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Enovis Announces Fourth Quarter and Full Year 2023 Results
- Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
- Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
- Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
- Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
- Enovis Introduces the DonJoy ROAM™ OA Knee Brace
- Enovis finalise l’acquisition de LimaCorporate S.p.A.
- エノビス (Enovis) がリマ・コーポレート (LimaCorporate S.p.A) の買収を完了
More ▼
Key statistics
On Friday, Enovis Corp (ENOV:NYQ) closed at 55.26, -16.45% below its 52-week high of 66.14, set on Jul 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 55.05 |
---|---|
High | 55.53 |
Low | 54.82 |
Bid | 54.68 |
Offer | 55.91 |
Previous close | 55.10 |
Average volume | 495.78k |
---|---|
Shares outstanding | 54.84m |
Free float | 51.70m |
P/E (TTM) | -- |
Market cap | 3.03bn USD |
EPS (TTM) | -0.9987 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 21:10 BST.
More ▼